1 / 22

Central anticholinergic syndrome (CAS)

Central anticholinergic syndrome (CAS). Dr. S. Parthasarathy MD., DA., DNB, MD ( Acu ), Dip. Diab . DCA, Dip. Software statistics,Ph D (physiology) Mahatma gandhi medical college and research institute, puducherry , India .

ronny
Download Presentation

Central anticholinergic syndrome (CAS)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Central anticholinergic syndrome (CAS) Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics,Ph D (physiology) Mahatma gandhi medical college and research institute, puducherry, India

  2. Central anticholinergic syndrome (CAS) is a clinical entity • which shows central and peripheral effects produced by over dosage • or abnormal reaction to clinical dosage of anticholinergic drugs

  3. Symptoms • Central • Peripheral • Lowest age reported is 4

  4. Central - Young patients

  5. Central old patients

  6. Central • Agitation • Amnesia • Ataxia • Asynergia • Confusion,excitement • Hallucinations • Delirium • Somnolence

  7. Central • Nausea • Emotional instability • Hyperpyrexia, • Hyperalgesia • Convulsions • Muscle incoordination

  8. Peripheral • Dry mouth • Dry skin • Arrhythmias • Mydriasis • Blurred vision • Micturition and bowel dysfunction • Thirst

  9. Almost no symptom is spared

  10. Basic mechanism • Cholinergic synapses necessary for memory • and anticholinergics ?? • Acetylcholine and anaesthetics • GABA modifies Cholinergic synapses • EEG behavioral dissociation

  11. Incidence • After GA, 9.4 % • After RA with sedation 3.3 % • Reported from 4 year child onwards • From Immediate postop to first week

  12. Old age- more incidence • The decreased cholinergic reserve in older persons • Other drugs

  13. Drugs and CAS • Antidepressants • Anticholinergics • Antipsychotics • Antispamodics • Halo,enflurane • Morphine, pethidine • Ketamine • Antiparkinson drugs

  14. What is this ?? • An elderly patient is scheduled for enucleation of a blind, painful eye. Scopolamine, 0.4 mg IM, premedication. • preoperative holding area, the patient becomes agitated and disoriented. • The only other medication the patient has received is 1%atropine eye drops.

  15. Differential diagnosis • Metabolic encephalopathy • ABG, renal parameters ,electrolytes • Neurologic damage • CT scan

  16. How to conclude as CAS • Method of exclusion • Profile • Physostigmine challenge • 0.04 mg / kg IV or IM • 5 – 15 minutes symptoms improve

  17. Physostigmine • A cholinesterase inhibitor • Rapidly hydrolysed • Raised BP and tachycardia !! • No problem with neostigmine • Analgesia • Usually one dose is enough

  18. Other drugs • Galantaminehydrobromide • 4 amino pyridine • Tacrine • But nonspecific

  19. Delayed recovery • naloxone and flumazenil, • Usually the patients recover to go back to sleep • In CAS , recovery after physostigmine is usually complete

  20. How to avoid ?? • Atropine • Phenergan • Physostigmine just before recovery

  21. Acta AnaesthesiolBelg. 1976;27(2):45-60 • treated 200 cases in which the CAS was diagnosed with physostigminesalicylate (0.04 mg/kg). • successfully treated 2 cases of apparently central anticholinergic hyperpyrexia in the same way. • suggest that physostigmine be included in the armamentarium of every anesthetist

  22. Thank you all

More Related